Gut check: bacteria linked to blood pressure in new study
NCT ID NCT06284928
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at the gut bacteria of 192 people, including those with untreated high blood pressure, treated high blood pressure, and healthy individuals. Researchers analyzed stool samples to find differences in bacteria types and functions. The goal was to understand how gut microbes relate to blood pressure and identify possible targets for better treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
192 people
The number who actually took part.
- Started
-
Dec 2019
- Finished
-
Dec 2020
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consists of adults aged 18 years or older recruited from the outpatient clinics and health examination centers of the First Affiliated Hospital of Xinjiang Medical University. Participants include three groups: newly diagnosed untreated hypertensive patients, hypertensive patients receiving medication but with uncontrolled blood pressure, and healthy controls without hypertension or major chronic diseases. All participants will provide stool samples for gut microbiota metagenomic analysis and basic clinical data collection.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria General Inclusion (applies to all participants) 1. Adults aged 18 years or older. 2. Able and willing to provide a stool sample for gut microbiota analysis. 3. Able to understand and sign written informed consent prior to participation. Cohort-Specific Inclusion A. Untreated Hypertension Group (Newly Diagnosed) 1. Newly diagnosed hypertension, defined as: Office blood pressure ≥140/90 mmHg, confirmed by at least two measurements on separate visits; or 24-hour ambulatory BP monitoring (ABPM): mean ≥130/80 mmHg, or daytime ≥135/85 mmHg, or nighttime ≥120/70 mmHg. 2. Never received any antihypertensive medication prior to enrollment. B. Uncontrolled Hypertension Group (On Medication) 1. Established hypertension, under stable antihypertensive therapy for ≥4 weeks. 2. Blood pressure not at target, defined as: Office BP ≥140/90 mmHg, or 24-hour ABPM mean ≥130/80 mmHg (daytime ≥135/85 mmHg, nighttime ≥120/70 mmHg). 3. No planned medication changes until stool sampling is completed. C. Healthy Control Groups 1. No history of hypertension or antihypertensive medication use. 2. Office BP \<130/80 mmHg (average of 2-3 readings). 3. Free from major chronic or gastrointestinal diseases. Exclusion Criteria 1. Use of antibiotics, probiotics, or prebiotics within the previous 3 months, or bowel preparation for colonoscopy within 4 weeks. 2. Chronic gastrointestinal diseases (e.g., inflammatory bowel disease, irritable bowel syndrome, celiac disease) or history of major gastrointestinal surgery (including bariatric surgery). 3. Presence of major chronic diseases that may confound gut microbiota or blood pressure regulation, including: Coronary artery disease (CAD) or other significant cardiovascular diseases; Diabetes mellitus (type 1 or type 2); Chronic kidney disease (stage ≥3); Chronic liver disease or hepatic failure; Heart failure (NYHA class III-IV); Active malignancy or history of cancer within the past 5 years. 4. Pregnancy or lactation. 5. Acute infection, acute gastrointestinal symptoms, or hospitalization within the past 4 weeks. 6. Special restrictive diets (e.g., ketogenic, elimination, or medically prescribed weight-loss diets) or alcohol/substance abuse that may alter gut microbiota. 7. Any other condition that, in the investigator's opinion, could interfere with participation, data integrity, or sample quality.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gut microbiota are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, 630000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pressing six points on the body help older adults sleep?
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Could a quieter, automated blood pressure check help more people control hypertension?
- Could gut bacteria predict lung trouble after surgery?
- Can a phone call boost confidence in managing high blood pressure?
- Smart pillbox aims to keep patients on track